Atlas Trials

A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

Clinical trial NCT01763580 · COMPLETED

Trial details

NCT number
NCT01763580
Sponsor
Astellas Pharma Korea, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
MCNSMinimal Change Nephrotic Syndrome (MCNS)
Start date
2012-07-16
Primary completion
2017-05-02
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.